Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Novartis Pharmaceuticals
Condition: Advanced Gastric Cancer
NCT01402401
Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.